NES
TEVA icon

New England Securities’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

New England Securities’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		$253K Buy
4,407
+2,276
+107% +$127K 0.09% 230
2014
Q3 		$115K Buy
2,131
+142
+7% +$7.52K 0.04% 385
2014
Q2 		$104K Buy
1,989
+106
+6% +$5.42K 0.04% 438
2014
Q1 		$100K Buy
1,883
+326
+21% +$15.1K 0.04% 391
2013
Q4 		$62K Sell
1,557
-414
-21% -$16.3K 0.03% 491
2013
Q3 		$74K Buy
1,971
+413
+27% +$16.1K 0.04% 419
2013
Q2 		$61K Buy
+1,558
New +$60.7K 0.04% 386

Other funds holding TEVA

Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $66.1B AUM 33.53% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $123B AUM 45.23% 1-Year Est. Return
MIP
Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

New England Securities's TEVA Position: Q4 2014 in Review

New England Securities increased its Teva Pharmaceutical Industries Limited (TEVA) stake by 107% in Q4 2014, buying an estimated $127K and bringing the position to 4,407 shares worth $253K. The position accounts for 0.09% of the portfolio, ranked #230.

New England Securities first reported a position in TEVA in Q2 2013 and has held it in 7 quarters since. 822 funds tracked by Wall St. Rank hold TEVA as of Q4 2014.

  • New England Securities held 4,407 shares of Teva Pharmaceutical Industries Limited worth $253K as of Q4 2014.
  • New England Securities bought 2,276 Teva Pharmaceutical Industries Limited shares in Q4 2014, an estimated $127K.
  • Teva Pharmaceutical Industries Limited made up 0.09% of New England Securities's portfolio in Q4 2014, its #230 holding.
  • New England Securities first reported a position in Teva Pharmaceutical Industries Limited in Q2 2013 and has held it in 7 quarters since.
  • 822 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q4 2014.

Based on New England Securities's 13F filing for Q4 2014, filed 26 Jan 2015.